Company intelligence / Profile preview

CTC Bio

Hwaseong-si, South Koreainvesting.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

CTC Bio Inc. manufactures pharmaceuticals for humans and animals, functional foods, medical devices, bio raw materials, and animal drugs. The company has a strong presence in South Korea with international expansion efforts—recently signing an exclusive supply agreement to launch its premature ejaculation drug "One-two Tab." in Taiwan. It also operates a joint venture manufacturing facility in Vietnam focused on regional markets such as Laos, Cambodia, Myanmar, and Korea. Its portfolio includes enzyme-based feed additives like "CTCZYME" to improve livestock digestion.[1][2][5]

Therapeutic areas
OtherMen's HealthGastroenterology
Modalities
Small molecules (human and animal pharmaceuticals)Enzymes (e.g., ß-mannanase in feed additives)Medical devices[1][4]
Industry
Biotech
02

Drug pipeline

4 assets

CDFR0613

3

3 more assets in the full pipeline.

Request access →
03

Partnerships

Chifu Pharmaceutical Distributor (Taiwan) – exclusive supply agreement for One-two Tab.[1]

Beyond the preview

Go deeper on CTC Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTC Bio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call